Vaccines (Dec 2021)

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study

  • Xiaozhen Lai,
  • He Zhu,
  • Jiahao Wang,
  • Yingzhe Huang,
  • Rize Jing,
  • Yun Lyu,
  • Haijun Zhang,
  • Huangyufei Feng,
  • Jia Guo,
  • Hai Fang

DOI
https://doi.org/10.3390/vaccines9121461
Journal volume & issue
Vol. 9, no. 12
p. 1461

Abstract

Read online

Coronavirus disease 2019 (COVID-19) booster vaccination has been proposed in response to the new challenges of highly contagious variants, yet few studies have examined public acceptance of boosters. This study examined public acceptance of COVID-19 booster vaccination and its influencing factors by using the data from a self-administered online cross-sectional survey conducted in June 2021 in China. Multiple logistic analysis was used to examine the influencing factors of booster acceptance based on the health belief model (HBM). Among 1145 respondents, 84.80% reported to accept COVID-19 booster vaccination. Having COVID-19 vaccination history, perceiving high benefits and low barriers to booster vaccination, being younger (18–30 vs. 41–50), having a lower education level, being employed, and belonging to priority groups for vaccination were associated with increased odds of booster acceptance. The primary reason for refusing booster vaccination was concern about vaccine safety. The vast majority (92.8%) of respondents reported an annual willingness to pay between 0 and 300 CNY (0–46.29 USD) if the booster was not free. Our findings suggest that the acceptance rate of booster vaccination is relatively high in China, and the HBM-based analysis reveals that more efforts are needed to increase perceived benefits and reduce perceived barriers of vaccination to design effective and proper vaccination extension strategies when boosters become widely recommended.

Keywords